Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

181.39 -4.26 (-2.29%)
Official Closing Price Updated: 7:00 PM EDT, Aug 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 639,694
Open 186.21
Bid (Size) 176.54 (100)
Ask (Size) 200.00 (100)
Prev. Close 185.65
Today's Range 179.20 - 187.14
52wk Range 73.16 - 191.62
Shares Outstanding 55,137,429
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today ↗
Glaukos (NYSE:GKOS) has outperformed the market over the past 5 years by 15.09% on an annualized basis producing an average annual return of 26.17%. Currently, Glaukos has a market capitalization of... 
Via Benzinga
News headline image
Glaukos Announces Participation in Wells Fargo Healthcare Conference
From Glaukos Corporation
Via Business Wire

Performance

YTD
+63.8%
+63.8%
1 Month
+19.4%
+19.4%
3 Month
+57.8%
+57.8%
6 Month
+52.2%
+52.2%
1 Year
+98.1%
+98.1%

More News

Read More
News headline image
Glaukos (GKOS) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Glaukos Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
GKOS (Glaukos Corp) Shows Strong Trend Template Compliance and High Growth Momentum on ChartMill ↗
Via Chartmill
Glaukos Corp (NYSE:GKOS) Shares Surge on Record Sales and Raised Guidance After Q1 Beat ↗
Via Chartmill
Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules ↗
Via Chartmill
News headline image
Glaukos Announces Second Quarter 2026 Financial Results
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Participation in Upcoming Investor Conferences
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos (GKOS) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Glaukos Announces First Quarter 2026 Financial Results
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces the Release of its 2025 Sustainability Report
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Receives Permanent J-code for Epioxa™
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
From Glaukos Corporation
Via Business Wire
News headline image
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
Via The Motley Fool
News headline image
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Glaukos Corporation Common Stock publicly traded?
Yes, Glaukos Corporation Common Stock is publicly traded.
What exchange does Glaukos Corporation Common Stock trade on?
Glaukos Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Glaukos Corporation Common Stock?
The ticker symbol for Glaukos Corporation Common Stock is GKOS on the New York Stock Exchange
What is the current price of Glaukos Corporation Common Stock?
The current price of Glaukos Corporation Common Stock is 181.39
When was Glaukos Corporation Common Stock last traded?
The last trade of Glaukos Corporation Common Stock was at 08/25/26 07:00 PM ET
What is the market capitalization of Glaukos Corporation Common Stock?
The market capitalization of Glaukos Corporation Common Stock is 10.00B
How many shares of Glaukos Corporation Common Stock are outstanding?
Glaukos Corporation Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.